| P2093 | author name string | Lei Jin | |
| | Qingyi Wei | |
| | Guojun Li | |
| | Erich M Sturgis | |
| | Zhongqiu Wang | |
| | Xicheng Song | |
| P2860 | cites work | Tobacco and cancer: recent epidemiological evidence | Q23919091 |
| | Human papillomavirus and survival of patients with oropharyngeal cancer. | Q27851567 |
| | Cancer statistics, 2012 | Q27860574 |
| | XPA polymorphism associated with reduced lung cancer risk and a modulating effect on nucleotide excision repair capacity | Q30908423 |
| | Evidence for a causal association between human papillomavirus and a subset of head and neck cancers | Q33180284 |
| | Nucleotide excision repair gene polymorphisms and recurrence after treatment for superficial bladder cancer. | Q33212495 |
| | Polymorphisms in nucleotide excision repair genes and DNA repair capacity phenotype in sisters discordant for breast cancer | Q33258084 |
| | Nucleotide excision repair pathway genes and oral premalignant lesions | Q33288021 |
| | Moving toward individualized therapy based on NER polymorphisms that predict platinum sensitivity in ovarian cancer patients | Q33297944 |
| | Association of TGF-beta1 genetic variants with HPV16-positive oropharyngeal cancer | Q33699084 |
| | Acute myeloid leukemia outcome: role of nucleotide excision repair polymorphisms in intermediate risk patients | Q34052352 |
| | HPV-associated head and neck cancer: a virus-related cancer epidemic | Q34114152 |
| | Rapid assessment of repair of ultraviolet DNA damage with a modified host-cell reactivation assay using a luciferase reporter gene and correlation with polymorphisms of DNA repair genes in normal human lymphocytes. | Q34158588 |
| | How nucleotide excision repair protects against cancer | Q34568150 |
| | Genetic susceptibility--molecular epidemiology of head and neck cancer | Q34617948 |
| | Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? | Q34667925 |
| | ERCC1 and ERCC2 polymorphisms predict clinical outcomes of oxaliplatin-based chemotherapies in gastric and colorectal cancer: a systemic review and meta-analysis | Q34694410 |
| | Cisplatin pharmacogenetics, DNA repair polymorphisms, and esophageal cancer outcomes | Q34902754 |
| | DNA repair phenotype and cancer susceptibility--a mini review | Q35146743 |
| | Genetic predictors of acute toxicities related to radiation therapy following lumpectomy for breast cancer: a case-series study | Q35605765 |
| | Enhanced XPA mRNA levels in cisplatin-resistant human ovarian cancer are not associated with XPA mutations or gene amplification. | Q36839232 |
| | DNA repair capacity in peripheral lymphocytes predicts survival of patients with non-small-cell lung cancer treated with first-line platinum-based chemotherapy | Q36910455 |
| | Association of p73 G4C14-to-A4T14 polymorphism with human papillomavirus type 16 status in squamous cell carcinoma of the head and neck in non-Hispanic whites. | Q37157792 |
| | Nucleotide excision repair core gene polymorphisms and risk of second primary malignancy in patients with index squamous cell carcinoma of the head and neck. | Q37214192 |
| | Associations between XPC polymorphisms and risk of cancers: A meta-analysis | Q37260828 |
| | XPD polymorphism and risk of subsequent cancer in individuals with nonmelanoma skin cancer | Q42465890 |
| | A Xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy in patients with advanced colorectal cancer. | Q42514558 |
| | Association between polymorphisms of ERCC1 and XPD and survival in non-small-cell lung cancer patients treated with cisplatin combination chemotherapy | Q43406715 |
| | Human papillomavirus type 16 infection and squamous cell carcinoma of the head and neck in never-smokers: a matched pair analysis | Q44509715 |
| | XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy | Q47405891 |
| | Polymorphisms of DNA repair genes XRCC1 and XPD and their associations with risk of esophageal squamous cell carcinoma in a Chinese population. | Q53388384 |
| | Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy. | Q53636339 |
| | An analysis of DNA repair as a determinant of survival in patients with non-small-cell lung cancer. | Q53964801 |
| | Genetic variation in the nucleotide excision repair pathway and colorectal cancer risk. | Q55042746 |
| | Genetic Variation in the Nucleotide Excision Repair Pathway and Bladder Cancer Risk | Q57568634 |
| | Single nucleotide polymorphisms in theXPGgene: Determination of role in DNA repair and breast cancer risk | Q57664913 |
| | Genetic polymorphisms of the XPG and XPD nucleotide excision repair genes in sarcoma patients | Q59358862 |
| | Head and neck cancer | Q70522684 |
| | DNA repair gene XRCC1 and XPD polymorphisms and risk of prostate cancer | Q75337173 |
| | Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control analysis | Q79428718 |
| | Potentially functional single nucleotide polymorphisms in the core nucleotide excision repair genes and risk of squamous cell carcinoma of the head and neck | Q80761051 |
| | Polymorphisms in the DNA nucleotide excision repair genes and lung cancer risk in Xuan Wei, China | Q81682241 |
| | Xeroderma pigmentosum group D haplotype predicts for response, survival, and toxicity after platinum-based chemotherapy in advanced nonsmall cell lung cancer | Q83223958 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 695-704 | |
| P577 | publication date | 2013-02-25 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | Variants in nucleotide excision repair core genes and susceptibility to recurrence of squamous cell carcinoma of the oropharynx | |
| P478 | volume | 133 | |